Profile
Corporate information
Official name
Armo BioSciences Inc
Registration country
Official name
Armo BioSciences Inc
Registration country
Investment activity status
Active investor
Company type
Late-stage immuno-oncology company.Funding
Funding rounds
Series C-1 USD 67,000,000
USD 67,000,000 (1 Sep 2017)
"The Series C-1 proceeds will be used to initiate phase 2/3 studies with ARMO’s lead immunotherapy agent AM0010 in non-small cell lung cancer and renal cell cancer and to support an ongoing pivotal phase 3 clinical trial in advanced pancreatic cancer. The
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Qiming Venture Partners | China | Initial investment. Led the round. | |
|
Decheng Capital | Initial investment. Round participant. | ||
|
Quan Capital Ltd | Alternative investment firm with a focus on control-oriented investments in small- and medium-sized enterprises. | Initial investment. Round participant. | |
|
RTW Investments | Initial investment. Round participant. | ||
|
Sequoia Capital Operations LLC | Venture capital firm. | United States | Initial investment. Round participant. |
|
|
Celgene Corp | Biopharmaceutical company committed to improving the lives of patients worldwide. | United States | Follow-on investment. Round participant. |
|
|
Clough Capital Partners LP | Follow-on investment. Round participant. | ||
|
Duff Ackerman & Goodrich Ventures | A mid-stage venture capital partnership with a service-oriented mindset. | United States | Follow-on investment. Round participant. |
|
GV. | The venture capital arm of Alphabet Inc. (Formerly Google Ventures.) | United States | Follow-on investment. Round participant. |
|
|
HBM Healthcare Investments | Follow-on investment. Round participant. | ||
|
Kleiner Perkins Caufield & Byers LLC | Venture capital firm. | United States | Follow-on investment. Round participant. |
|
NanoDimension Inc | United States | Follow-on investment. Round participant. | |
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States | Follow-on investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Celgene Corp Biopharmaceutical company committed to improving the lives of patients worldwide. |
Series C-1 | |
|
|
Clough Capital Partners LP |
Series C-1 | |
|
|
Decheng Capital |
Series C-1 | |
|
|
Duff Ackerman & Goodrich Ventures A mid-stage venture capital partnership with a service-oriented mindset. |
+1 (415) 788-2755 |
Series C-1 |
|
|
GV. The venture capital arm of Alphabet Inc. (Formerly Google Ventures.) |
Series C-1 | |
|
|
HBM Healthcare Investments |
Series C-1 | |
|
|
Kleiner Perkins Caufield & Byers LLC Venture capital firm. |
+1 (650) 233-2750 |
Series C-1 |
|
|
NanoDimension Inc |
+1 (650) 241-1155 |
Series C-1 |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
Series C-1 |
|
|
Qiming Venture Partners |
Series C-1 | |
|
|
Quan Capital Ltd Alternative investment firm with a focus on control-oriented investments in small- and medium-sized enterprises. |
Series C-1 | |
|
|
RTW Investments |
Series C-1 | |
|
|
Sequoia Capital Operations LLC Venture capital firm. |
+1 (650) 854-3927 |
Series C-1 |